Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-09-15

FDA Approved: METOPROLOL — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for metoprolol tartrate products from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL (METOPROLOL TARTRATE)

Snippet

SUPPL AP for METOPROLOL (METOPROLOL TARTRATE)